T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Spyridoula Vasileiou, Premal D. Lulla, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Wendy L. Callejas, Mrinalini Bilgi, Tao Wang, Mengfen J. Wu, Rammurti Kamble, Carlos A. Ramos, Rayne H. Rouce, Zihua Zeng, Adrian P. Gee, Bambi J. Grilley, Juan F. Vera, Catherine M. Bollard, Malcolm K. Brenner, Helen E. Heslop, Cliona M. RooneyAnn M. Leen, George Carrum

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects'. Together they form a unique fingerprint.

Medicine & Life Sciences